Phase I study of an all-oral combination of vinorelbine (VRL) and cyclophosphamide (Ctx) as second line treatment in patients with metastatic breast cancer (MBC)

被引：0
|
作者：
ten Tije, AJ
Lieverst, J
Seynaeve, C
Schornagel, JH
Brandely, M
Blanchot, G
ter Steeg, JD
Verweij, J
Schellens, JHM
机构：
[1] Erasmus Med Ctr, Dept Med Oncol, Rotterdam, Netherlands
[2] Antoni Van Leeuwenhoek Ziekenhuis, Dept Med Oncol, Amsterdam, Netherlands
[3] Pierre Fabre Medicament, Inst Rech, Boulogne, France
来源：
EUROPEAN JOURNAL OF CANCER | 2002年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
124
引用
收藏
页码：S42 / S42
页数：1
相关论文
共 50 条
  • [1] Phase II study of an all-oral combination of vinorelbine with capecitabine in patients with metastatic breast cancer
    Nole, Franco
    Crivellari, D.
    Mattioli, R.
    Pinotti, G.
    Foa, P.
    Verri, E.
    Fougeray, R.
    Brandely, M.
    Goldhirsch, A.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 64 (04) : 673 - 680
  • [2] Phase II study of an all-oral combination of vinorelbine with capecitabine in patients with metastatic breast cancer
    Franco Nolè
    D. Crivellari
    R. Mattioli
    G. Pinotti
    P. Foa
    E. Verri
    R. Fougeray
    M. Brandely
    A. Goldhirsch
    Cancer Chemotherapy and Pharmacology, 2009, 64 : 673 - 680
  • [3] Phase I combination study of oral vinorelbine and oral cyclophosphamide in patients with metastatic breast cancer
    Ten Tije, AJ
    Lieverst, J
    Seynaeve, C
    Schornagel, J
    Feragotto, N
    Blanchot, G
    Ter Steeg, JD
    Laffranchi, B
    Verweij, J
    Schellens, JH
    Erasmus, MC
    BREAST CANCER RESEARCH AND TREATMENT, 2003, 82 : S87 - S87
  • [4] ALL ORAL COMBINATION OF VINORELBINE AND CAPECITABILE AS A FIRST LINE TREATMENT IN PATIENTS (PTS) WITH METASTATIC BREAST CANCER (MBC)
    Shehata, Samir
    Khalaf, Marwa
    BREAST, 2017, 36 : S53 - S53
  • [5] All oral combination of vinorelbine and capecitabine as a first line treatment in patients (pts) with metastatic breast cancer (MBC)
    Shehata, S.
    Khalaf, M.
    ANNALS OF ONCOLOGY, 2017, 28
  • [6] A phase I study of an all-oral combination of vinorelbine/capecitabine in patients with metastatic breast cancer previously treated with anthracyclines and/or taxanes
    Kellokumpu-Lehtinen, Pirkko-Liisa
    Sunela, Kaisa
    Lehtinen, Ilari
    Joensuu, Heikki
    Sjostrom-Mattson, Johanna
    CLINICAL BREAST CANCER, 2006, 7 (05) : 401 - 405
  • [7] An all-oral combination of capecitabine W and cyclophosphamide (C): Findings from a phase I study and an additional feasibility study in patients (pts) with metastatic breast cancer (MBC).
    Ohno, S
    Mitsuyama, S
    Tamura, K
    Nishimura, R
    Tanaka, M
    Hamada, Y
    Kuroki, S
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 90S - 90S
  • [8] Phase II study of vinorelbine (VRL) alternating i.v. and oral in combination with docetaxel (DTX) as list line chemotherapy (CT) of metastatic breast cancer (MBC)
    Blasinska-Morawiec, M.
    Campone, M.
    Tekiela, A.
    Koralewski, P.
    Longerey, B.
    Douville, I.
    EJC SUPPLEMENTS, 2005, 3 (02): : 128 - 128
  • [9] An all-oral combination regimen of vinorelbine and capecitabine for elderly patients with metastatic breast cancer
    Carreca, Ignazio
    Bronte, Giuseppe
    Burgio, Marco
    Carreca, Annapaola
    Piazza, Dario
    Rizzo, Sergio
    Russo, Salvatore
    ANNALS OF ONCOLOGY, 2006, 17 : 159 - 159
  • [10] Phase II study of an all-oral regimen combining oral vinorelbine with capecitabine as first-line chemotherapy (CT) of metastatic breast cancer (MBC)
    Nole, F.
    Catania, C.
    Sanna, G.
    Mattioli, R.
    Crivellari, D.
    Foa, P.
    Pinotti, G.
    Imadalou, K.
    Bodini, A.
    Goldhirsch, A.
    EJC SUPPLEMENTS, 2007, 5 (04): : 218 - 218
12345